Tchaikapharma High Quality Medicines : Minutes from a General shareholders meeting

Minutes from a General shareholders meeting 30.09.2022 11:29:19 (local time)

Company: Tchaikapharma High Quality Medicines AD-Sofia (THQM)
The extraordinary General Meeting of Shareholders of Tchaikapharma High Quality Medicines AD dated 29 September 2022 has passed the following resolutions:
- Adoption of a decision, the company to enter as a joint debtor for the entire amount, term and conditions under a bank credit-overdraft agreement for EUR 3,600,000 concluded between Commercial League - Global Pharma Center AD, UIC 030276307, and CB UBB, UIC 000694959
Debt maturity: Until 15 May 2023
- Assigning the executive director, Biser Georgiev, personally or through a person authorised by him, to carry out all the necessary factual and legal actions for the implementation of the decision under the first item of the agenda
- In connection with a letter received from the Financial Supervision Commission, according to which the company was notified of the need to comply with the provisions of Art. 197 of the Commerce Act, according to which the term in which a GMS can decide to increase the capital with own funds is no later than three months after the adoption of the annual financial report for the past year, the EGM does not subject to a vote the following items of the agenda respectively does not decide on them: "Adopting a decision on the distribution of the profit realised in 2020 and 2021" and "Adopting a decision on monetary compensation in favour of all minority shareholders who cannot subscribe a whole share in the upcoming capital increase"
The Record of Proceedings taken at the company's EGM is available on the website of the Exchange.
The entire piece of news is published on the financial website X3News.